Skip to content

The effect of different doses of esketamine on postoperative depression in elderly patients with urological tumors undergoing laparoscopic surgery

The effect of different doses of esketamine on postoperative depression in elderly patients with urological tumors undergoing laparoscopic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117718
Enrollment
Unknown
Registered
2026-01-28
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative depression

Interventions

Low-dose Esketamine Group:Esketamine 0.15 mg/kg was administered intravenously during induction.
Moderate-dose Esketamine Group:Esketamine 0.3 mg/kg was administered intravenously during induction.

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Elective laparoscopic urological tumor surgery; 2. ASA grade II-III; 3. Age >=65 years old; 4. Bmi18.5-27.9 kg/?.

Exclusion criteria

Exclusion criteria: 1.Severe cognitive impairment before surgery 2.Hypersensitivity and contraindications to esketamine (including patients with severely elevated intracranial pressure; patients with untreated or poorly controlled hypertension; patients with glaucoma; patients with untreated or undertreated hyperthyroidism; patients with adrenal pheochromocytoma; patients with epilepsy) 3.Complicated with severe cardiovascular diseases (e.g., myocardial infarction, heart failure, malignant arrhythmia, etc.), renal diseases (glomerular filtration rate = 2 mg/dl) 4.Geriatric Depression Scale-15 (GDS-15) score > 5 points before surgery 5.Recent administration of antidepressants or receipt of other antidepressant therapies 6.Patients with moderate to severe anemia (hemoglobin < 90 g/L) 7.A history of substance abuse, psychiatric disorders, communication disorders, etc.

Design outcomes

Primary

MeasureTime frame
Incidence of depression within 3 days after surgery;HADS score;

Secondary

MeasureTime frame
AIS score;MMSE score;Time from the end of the operation to extubation;Perioperative propofol, remifentanil consumption;Intraoperative vasoactive drug use;The incidence of postoperative adverse reactions . . "postoperative"? , AI ;Administration of analgesic drugs within 24 hours after surgery;VAS pain score;The first time of the postoperative exhaust;

Countries

China

Contacts

Public ContactGuanglei Wang

Affiliated Hospital of Xuzhou Medical University

13852087156@163.com+86 138 5208 7156

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026